SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer.
about
The ZEB/miR-200 feedback loop--a motor of cellular plasticity in development and cancer?EMT or EMT-Promoting Transcription Factors, Where to Focus the Light?Four amino acids within a tandem QxVx repeat in a predicted extended α-helix of the Smad-binding domain of Sip1 are necessary for binding to activated Smad proteinsEMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancerOverexpression of SATB1 is associated with biologic behavior in human renal cell carcinoma.Prognostic significance of ZEB1 and ZEB2 in digestive cancers: a cohort-based analysis and secondary analysis.Zinc Finger E-Box Binding Protein 2 (ZEB2) Suppress Apoptosis of Vascular Endothelial Cells Induced by High Glucose Through Mitogen-Activated Protein Kinases (MAPK) Pathway ActivationEither ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner.SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylationCore epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypesp63 expression defines a lethal subset of muscle-invasive bladder cancers.Overexpression of ZEB2 in peritumoral liver tissue correlates with favorable survival after curative resection of hepatocellular carcinoma.MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cellsEGF-induced EMT and invasiveness in serous borderline ovarian tumor cells: a possible step in the transition to low-grade serous carcinoma cells?ZEB2 mediates multiple pathways regulating cell proliferation, migration, invasion, and apoptosis in glioma.Protein expression of ZEB2 in renal cell carcinoma and its prognostic significance in patient survivalA pathway for the control of anoikis sensitivity by E-cadherin and epithelial-to-mesenchymal transition.A Review of ERCC1 Gene in Bladder Cancer: Implications for Carcinogenesis and Resistance to ChemoradiotherapyEpithelial to mesenchymal transition and the generation of stem-like cells in pancreatic cancer.Co-Expression of TWIST1 and ZEB2 in Oral Squamous Cell Carcinoma Is Associated with Poor SurvivalMathematical Modelling of Molecular Pathways Enabling Tumour Cell Invasion and Migration.The transcription factor Zeb2 regulates signaling in mast cellsCo-expression of ERCC1 and Snail is a prognostic but not predictive factor of cisplatin-based neoadjuvant chemotherapy for bladder cancerCisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes.Activation of the ATM-Snail pathway promotes breast cancer metastasis.Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancer.A Polycomb-mir200 loop regulates clinical outcome in bladder cancer.Mechanisms that link the oncogenic epithelial-mesenchymal transition to suppression of anoikis.Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression.Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer.MYC associated zinc finger protein promotes the invasion and metastasis of hepatocellular carcinoma by inducing epithelial mesenchymal transitionCirculating tumor cells: advances in detection methods, biological issues, and clinical relevance.MicroRNA Control of Invasion and Metastasis Pathways.Evolutionary functional analysis and molecular regulation of the ZEB transcription factors.Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer.The rejuvenated scenario of epithelial-mesenchymal transition (EMT) and cancer metastasis.ZEB/miR-200 feedback loop: at the crossroads of signal transduction in cancer.Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies.EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness.
P2860
Q24617121-8C44784D-88F7-4E86-90FF-2048421D04E1Q26995188-7C124723-9E4A-4102-81C0-0F1BD7AF44BFQ28534349-09FB7625-6932-4B63-87C8-6B4A136E319EQ29616360-C1FA1BA6-5277-4DE6-82BF-E128E94F8968Q33623663-47FAE2FF-CFA0-48F3-B1DE-79A81C6D1714Q33761782-A3248F05-9766-49FC-A28A-5430A9DDB5A1Q33764076-1D2AB912-B7F0-4E34-BE18-A1FD4083E08DQ33877497-B5293BEF-3BCB-42D4-951A-035C9C374445Q33924619-104F03A3-8F0A-42D8-939C-ACB9A51E6094Q34100400-D29BAF10-966A-4F4A-9491-0856BD0B306BQ34131185-53F1EB26-C12D-4659-9B7C-0F0C98397734Q34186021-4A47B94F-D949-41C1-A05F-8F5A8189CA1CQ34209054-D226359F-1A92-4282-9A15-B0CA4EA71762Q34222070-E30EC3A9-FCC3-48DC-8AD9-62F1B3A42BEDQ34325808-85BE7A3B-8B69-443D-ABEE-795CDCB1E540Q34712612-21BF1304-BCA7-4A9F-82A4-B8015A225CC6Q35273882-55B29921-E6A6-44F1-898F-C6D5A1AFBC66Q35495280-8FDC45F5-D69A-4131-9D6C-AC6E5C540468Q35582119-3F3B3F0B-EB22-4B54-ACEE-377054205876Q35716304-D2F1B64A-428F-439B-B28C-2CE7DB8FAD4DQ35830233-2CB4ED58-2978-42C4-ADB5-3F2126B2C4FAQ36016557-4916BE77-7AE5-4669-B759-6E2BF718321FQ36099310-66B3E7A1-3A59-436F-816B-799C68AF9316Q36105474-D0194341-E60B-442C-BE15-EC1621803F6CQ36297899-4F2D5801-6E30-4B99-92FA-0EAC20A17904Q36326301-52791B32-AFD0-4A43-9992-F7251EBD3F1EQ36561739-B419E5C5-AA6F-418A-A56C-1CD0CE79D302Q36702544-F34E6287-F3B4-44D2-8B3D-CCBF50C2589DQ37044614-7F9E1F72-B839-432A-AA12-AEA38E9D22BEQ37615676-45A667A2-C3CA-43D9-93FC-94F9AEAF1FDCQ37655607-EDBAA89F-440D-4D78-9989-9736E1275C17Q37699248-891CBC1C-635D-4CE1-8139-3AF7BC85978FQ37890969-CE1DD8A9-F223-46AC-9E5A-AED0D2349BDAQ37981156-BC7F0A5C-C9F6-4D7B-B06B-8A18520A5BF9Q37986328-8D69B47C-8CB7-4FD7-BC9D-38F8EAA17F25Q38021354-9E48B934-C20C-4A3D-A2A2-945AE4B183B6Q38021684-27B7C75A-7AA3-4B35-8483-4591F18EF1E7Q38023321-1D4047C7-9715-4556-A3E0-E392CF466835Q38024791-A845DA02-38D9-49E1-AEF2-FB69CDDBAB6BQ38040369-4AE656A0-ECCB-4F45-B4EF-1730D1C1C36A
P2860
SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
SIP1 protein protects cells fr ...... ostic value in bladder cancer.
@en
SIP1 protein protects cells fr ...... ostic value in bladder cancer.
@nl
type
label
SIP1 protein protects cells fr ...... ostic value in bladder cancer.
@en
SIP1 protein protects cells fr ...... ostic value in bladder cancer.
@nl
prefLabel
SIP1 protein protects cells fr ...... ostic value in bladder cancer.
@en
SIP1 protein protects cells fr ...... ostic value in bladder cancer.
@nl
P2093
P2860
P50
P356
P1476
SIP1 protein protects cells fr ...... nostic value in bladder cancer
@en
P2093
Alexandra Colquhoun
Andrew Ruddick
Eugene Tulchinsky
Gareth J Browne
Hasan Qazi
J Kilian Mellon
Karen J Bowman
Marina Kriajevska
Nick J Mayer
P2860
P304
14884-14889
P356
10.1073/PNAS.0902042106
P407
P577
2009-08-17T00:00:00Z